Posted in | News | Business | Composites | Energy

Dow Announces Acquisitions of Epoxy Formulators

Dow Epoxy, a global business unit of The Dow Chemical Company and its affiliates (“Dow”), announced today that it has completed the acquisitions of three epoxy systems formulators – UPPC AG in Germany, and GNS Technologies and POLY-CARB Inc. in the United States. Dow announced its intention to acquire the three formulators on September 13, pending regulatory approvals and standard closing conditions.

“We are pleased to complete the acquisitions and add such high-performing businesses to our Epoxy Systems portfolio,” said Pepe Carnevale, global business director for Dow Epoxy Systems. “All three companies are leading players in their respective markets and their vast experience in systems fits well with our rich technology. Bringing those two elements together will enable us to deliver more value to customers, including enhancements to products and services and the development of unique material solutions.”

Dow Epoxy Systems and its affiliates focus on applications in civil engineering and infrastructure, composites, wind energy, and other industries where their unique technologies and systems solutions can offer performance enhancement and differentiation to customers.

“We are pleased to welcome UPPC, GNS and POLY-CARB employees onto the Dow Epoxy Systems team and look forward to the success we will achieve together,” said Carnevale. “Our immediate goal is to ensure continued excellence in customer service and to begin accelerating product development and other growth activities.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.